Henry Schein, Inc. announced an expansion of its agreement with vVARDIS granting the company exclusive U.S. distribution rights for Curodont™ Repair Fluoride Plus across all dental market segments effective January 1, 2026. The expansion builds on an exclusivity arrangement announced in 2024 for dental service organizations (DSOs).
The agreement will extend to general dentistry, orthodontics, and pediatric dentistry, according to a press release. Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein, said, “We are pleased to build upon our existing relationship with vVARDIS, the company behind a product that has seen remarkable success and growth in the dental industry. This expansion is a testament to our shared commitment of helping dental professionals operate more efficient practices, all while advancing the oral and overall health of their communities.”
Curodont™ is described as a proprietary solution for treating patients with early-stage cavities using a drill- and needle-free application. The release cites research from the International Journal of Epidemiology concluding that people with fewer permanent teeth and untreated cavities were associated with higher all-cause and heart disease mortality. It also states that up to 80% of all patients have early-stage cavities and that many have previously left dental offices without treatment.
In the press release, Drs. Haley and Goly Abivardi, Founders and Co-CEOs of vVARDIS, said, “Our decision to broaden the relationship with Henry Schein was driven by the exceptional success we have already achieved, having accessed over 10% of U.S. dental offices and having treated more than 500,000 patients. The foundation of trust, shared goals, and delivered growth made it clear that Henry Schein is the right partner to make Curodont accessible to the entire U.S. dental community.”
Henry Schein currently distributes Curodont™ to general practitioners and Dental Service Organizations in the United States. The Company also distributes the product exclusively in the United Kingdom and holds non-exclusive distribution rights in other regions.
More information is available at www.henryschein.com and www.vvardis.com.
